课题基金 / 基金详情

CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS

CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORS
通过凝集素受体控制同种异体 NK 细胞裂解
批准号:
6362375
负责人:
JAMES C RYAN
金额:
$27.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2004-02-29

项目摘要

项目成果

JAMES C RYAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) The goal of the project described in this application is to define the receptor systems controlling the recognition of MHC I by rat NK cells. Functional studies show that rat NK cells must express MHC-binding receptors inhibits (allo-inhibition) or activates (allo-activation) natural killing. T identify these receptors, the investigators have localized the genes controlling NK cell alloresponses near or within the Ly-49 locus of lectin-like receptors on rat chromosome 4. They have shown that NK cells form rats that are defective in alloactivation are also deficient in Ly-49 expression. They have cloned and sequenced 5 members of the rat Ly-49 family and have raised mAbs reactive against 2 Ly-49 proteins. They have also produced new mAbs against receptors implicated in NK cell alloresponses, and they have cloned these receptor cDNAs. One receptor (STOK1/2) is a novel L-49 molecule, and the others comprise a previously undescribed family of NK lectins, which they have termed STOK9.Their objective is to show that the Ly-49 and STOK9 receptors control NK cell allo-inhibition and allo-activation in rats. Toward this end they have 5 specific aims. 1] Expand the panel of Ly-49 antibodies for use in Ly-49 functional studies. 2] Using blocking or stimulating anti-Ly-49 mAbs, they will examine the MHC specificities of each Ly-49 on rat NK cells and on Ly-49-transfected RNK-16 cell lines. 3] They will clone cDNAs encoding new members of the STOK9 family. 4] They will produce mAbs specific for newly cloned STOK9 proteins. 5] As in Aim 2, they will use these reagents to examine the MHC specificities of STOK9 receptors on rat NK cells and on STOK9-transfected RNK-16 cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of effective innate immunity in HCV treatment
Mechanisms of effective innate immunity in HCV treatment
HCV resolution correlates with patterned KIR expressions on lymphocytes.
HCV resolution correlates with patterned KIR expressions on lymphocytes.
国内基金
海外基金
CAN/lectin 7信号通路调控棉铃虫对Cry1Ac蛋白的免疫机制解析
  • 批准号:
    32172401
  • 项目类别:
    面上项目
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    魏纪珍
  • 依托单位:
血栓调节蛋白lectin区优势突变引起血栓形成的分子机制及其干预措施
  • 批准号:
    81973995
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    唐亮
  • 依托单位:
靶向Lectin受体多功能分子探针的构建及其在结直肠癌诊治中的实验研究
  • 批准号:
    81371614
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    贾兵
  • 依托单位:
免疫识别因子lectin在鳞翅目寄主昆虫识别寄生蜂为“非我”过程中的作用机制研究
  • 批准号:
    31272091
  • 项目类别:
    面上项目
  • 资助金额:
    85.0万元
  • 批准年份:
    2012
  • 负责人:
    胡建
  • 依托单位: